What question did this study set out to answer?

To assess the prognostic value of pretreatment MRI in predicting outcomes after radical prostatectomy.

April 4, 2026JAMA Oncology5 citations

Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy

GAGeorgios AgrotisDutch Cancer Society SUStephan UrsprungThe Netherlands Cancer Institute CSCasper van der SteenThe Netherlands Cancer Institute

Key Points

To assess the prognostic value of pretreatment MRI in predicting outcomes after radical prostatectomy.
Conducted a systematic review and meta-analysis of existing studies
Included data on biochemical recurrence, metastatic failure, and prostate cancer-specific mortality
Adjusted for established clinicopathologic factors.
Pretreatment MRI independently predicts biochemical recurrence
MRI is linked to metastatic failure rates
MRI correlates with prostate cancer-specific mortality.

Abstract

This systematic review and meta-analysis found that pretreatment MRI provides independent prognostic value for biochemical recurrence, metastatic failure, and prostate cancer-specific mortality in men undergoing radical prostatectomy, even when adjusted for established clinicopathologic factors.

Demander à l'IA

Bookmark

View Full Paper